Legal Representation
Attorney
Ajay A. Jagtiani
USPTO Deadlines
Next Deadline
977 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-03-22)
Due Date
March 22, 2028
Grace Period Ends
September 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 21, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Aug 8, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 8, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 8, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 8, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 8, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 22, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 15, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Feb 12, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Dec 17, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 16, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 18, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 18, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jun 19, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 17, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 17, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 17, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 7, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Dec 29, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 3, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 3, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 14, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 27, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 27, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 27, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 24, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 21, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 21, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 21, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 19, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 19, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 19, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 18, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 30, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 24, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products for use in the treatment of genetic diseases and disorders
First Use Anywhere:
Aug 13, 2020
First Use in Commerce:
Oct 25, 2021
Class 040
Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents
First Use Anywhere:
Aug 12, 2020
First Use in Commerce:
Aug 12, 2020
Class 042
Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays
First Use Anywhere:
Aug 12, 2020
First Use in Commerce:
Aug 12, 2020
Additional Information
Pseudo Mark
AN DELYN BIOSCIENCES
Classification
International Classes
005
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"